{
    "pmcid": "7870875",
    "qa_pairs": {
        "What are the IC50 values of W25 for neutralizing the D614 and G614 variants of SARS-CoV-2?": [
            "9.82 nM and 5.09 nM, respectively.",
            "15.5 nM and 7.2 nM, respectively.",
            "25.0 nM and 12.5 nM, respectively.",
            "50.0 nM and 30.0 nM, respectively."
        ],
        "What is the dissociation constant (Kd) of W25 when binding to the Spike RBD?": [
            "Approximately 295 pM.",
            "Approximately 500 nM.",
            "Approximately 1.5 \u00b5M.",
            "Approximately 10 nM."
        ],
        "What is the origin of nanobodies as described in the study?": [
            "Nanobodies are derived from the heavy-chain only antibodies (HCAbs) found in camelids, such as alpacas.",
            "Nanobodies are derived from the light-chain only antibodies found in rodents.",
            "Nanobodies are derived from the full-length antibodies found in humans.",
            "Nanobodies are derived from the single-chain antibodies found in birds."
        ],
        "What potential application is suggested for W25 in diagnostic assays?": [
            "W25 can be used in ELISA and immunofluorescence assays to detect the Spike protein.",
            "W25 can be used in Western blot assays to detect viral RNA.",
            "W25 can be used in PCR assays to amplify viral DNA.",
            "W25 can be used in mass spectrometry to identify viral proteins."
        ],
        "What was the method used to select the nanobody W25?": [
            "A Ficoll density gradient and E. coli surface display method was used.",
            "A phage display library and magnetic bead selection method was used.",
            "A yeast two-hybrid system and flow cytometry method was used.",
            "A mammalian cell display and fluorescence-activated cell sorting method was used."
        ]
    }
}